Literature DB >> 29320302

Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission.

Steven Joffe1, Holly Fernandez Lynch1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29320302     DOI： 10.1056/NEJMp1714054

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Right to Try Requests and Oncologists' Gatekeeping Obligations.

Authors:  Holly Fernandez Lynch; Ameet Sarpatwari; Robert H Vonderheide; Patricia J Zettler
Journal:  J Clin Oncol       Date:  2019-10-15       Impact factor: 44.544

2.  The Critical Role of Medical Institutions in Expanding Access to Investigational Interventions.

Authors:  Kayte Spector-Bagdady; Kevin J Weatherwax; Misty Gravelin; Andrew G Shuman
Journal:  Hastings Cent Rep       Date:  2019-03       Impact factor: 2.683

3.  From "Ought" to "Is": Surfacing Values in Patient and Family Advocacy in Rare Diseases.

Authors:  Meghan C Halley
Journal:  Am J Bioeth       Date:  2021-12       Impact factor: 11.229

4.  RxLegal: A Rapid Review of Right-To-Try.

Authors:  Michael Gabay
Journal:  Hosp Pharm       Date:  2018-06-20

Review 5.  Ethical and legal considerations related to disorders of consciousness.

Authors:  Lauren Rissman; Erin Talati Paquette
Journal:  Curr Opin Pediatr       Date:  2020-12       Impact factor: 2.856

6.  Expanded Access and Right To Try Requests: The Community Oncologist's Experience.

Authors:  Marjorie E Zettler; Yolaine Jeune-Smith; Bruce A Feinberg; Eli G Phillips; Ajeet Gajra
Journal:  JCO Oncol Pract       Date:  2021-04-22

Review 7.  Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?

Authors:  Elihu Estey; Judith E Karp; Ashkan Emadi; Megan Othus; Robert Peter Gale
Journal:  Leukemia       Date:  2020-01-08       Impact factor: 12.883

8.  "I Think It's Been Met With a Shrug:" Oncologists' Views Toward and Experiences With Right-to-Try.

Authors:  Cambray Smith; Jeremiah Stout; Alex A Adjei; Jan Buckner; Mark Wentworth; Jon Tilburt; Zubin Master
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

9.  Expanded Access as a source of real-world data: An overview of FDA and EMA approvals.

Authors:  Tobias B Polak; Joost van Rosmalen; Carin A Uyl-de Groot
Journal:  Br J Clin Pharmacol       Date:  2020-04-07       Impact factor: 4.335

10.  Right now, in the right way: U. S. Food and Drug Administration's expanded access program and patient rights.

Authors:  M E Blair Holbein; Kevin J Weatherwax; Misty Gravelin; Raymond Hutchinson; George A Mashour
Journal:  J Clin Transl Sci       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.